Can a tablet or VR headset help cancer patients recover at home?

NCT ID NCT07390071

Recruiting now Symptom relief Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a home-based telerehabilitation program for adults with lymphoma or myeloma who have received CAR-T cell therapy. Participants use a tablet or VR headset, along with a pulse oximeter and Fitbit, to follow personalized exercise and nutrition plans. The goal is to see if this approach is feasible and improves quality of life and recovery. The study enrolls 40 people and focuses on usability and adherence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Home Automated Telemanagement (HAT) patient unit (device including tablet or VR headset, pulse oximeter, and Fitbit)
What this could lead to: If successful, this could show that a home-based rehab program improves quality of life and recovery for blood cancer patients after CAR-T therapy.
What could go wrong: This is a small pilot study with only 40 participants, so results may not apply to everyone. The program's success depends on patient adherence and technology usability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOKINE RELEASE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytokine release syndrome lymphoma plasma cell myeloma plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOKINE RELEASE SYNDROME IMMUNE EFFECTOR CELL ASSOCIATED NEUROTOXICITY SYNDROME LYMPHOMA MYELOMA

Contacts and locations

Locations

Huntsman Cancer Institute at University of Utah
RECRUITING

Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.